{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:53:33Z","timestamp":1793962413614,"version":"4.8.0"},"reference-count":262,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40659-017-0140-9","type":"journal-article","created":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T11:28:23Z","timestamp":1506943703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1099,"title":["Awareness and current knowledge of breast cancer"],"prefix":"10.1186","volume":"50","author":[{"given":"Muhammad","family":"Akram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehwish","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Daniyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmat Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,2]]},"reference":[{"key":"140_CR1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S1470-2045(08)70179-7","volume":"9","author":"M Coleman","year":"2008","unstructured":"Coleman M, Quaresma M, Berrino F, Lutz JM, Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9:730\u201356.","journal-title":"Lancet Oncol"},{"key":"140_CR2","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/cncr.23844","volume":"113","author":"B Anderson","year":"2008","unstructured":"Anderson B, Yip C, Smith R, Shyyan R, Sener S, Eniu A, et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the breast health global initiative global summit 2007. Cancer. 2008;113:2221\u201343.","journal-title":"Cancer"},{"key":"140_CR3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"140_CR4","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJMoa050518","volume":"353","author":"D Berry","year":"2005","unstructured":"Berry D, Cronin K, Plevritis S, Fryback D, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784\u201392.","journal-title":"N Engl J Med"},{"key":"140_CR5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2174\/187152009788451833","volume":"9","author":"J Peng","year":"2009","unstructured":"Peng J, Sengupta S, Jordan VC. Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer. Anti-Cancer Agents Med Chem. 2009;9:481\u201399.","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"140_CR6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-0-387-73161-2_10","volume":"141","author":"J Reeder","year":"2008","unstructured":"Reeder J, Vogel V. Breast cancer prevention. Cancer Treat Res. 2008;141:149\u201364.","journal-title":"Cancer Treat Res"},{"key":"140_CR7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.7314\/APJCP.2013.14.3.1565","volume":"14","author":"R Abdull","year":"2013","unstructured":"Abdull R, Noor N. Cruciferous vegetables: dietary phytochemicals for cancer prevention. Asian Pac J Cancer Prev. 2013;14:1565\u201370.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"140_CR8","first-page":"1989","volume":"12","author":"V Dwivedi","year":"2011","unstructured":"Dwivedi V, Shrivastava R, Hussain S. Comparative anticancer potential of clove (Syzygium aromaticum)\u2014an Indian spice\u2014against cancer cell lines of various anatomical origin. Asian Pac J Cancer Prev. 2011;12(8):1989\u201393.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR9","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.7314\/APJCP.2012.13.12.6073","volume":"13","author":"J Mary","year":"2012","unstructured":"Mary J, Vinotha P, Pradeep A. Screening for in vitro cytotoxic activity of seaweed, Sargassum sp. against Hep-2 and MCF-7 cancer cell lines. Asian Pac J Cancer Prev. 2012;13:6073\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jep.2005.09.024","volume":"103","author":"P Mukherjee","year":"2006","unstructured":"Mukherjee P, Wahile A. Integrated approaches towards drug development from Ayurveda and other Indian system of medicines. J Ethnopharmacol. 2006;103:25\u201335.","journal-title":"J Ethnopharmacol"},{"key":"140_CR11","first-page":"2837","volume":"12","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Zhou L, Jiao S, Xu L. Relationship between soy food intake and breast cancer in China. Asian Pac J Cancer Prev. 2011;12:2837\u201340.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR12","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.7314\/APJCP.2013.14.10.6081","volume":"14","author":"S Han","year":"2013","unstructured":"Han S, Guo Q, Wang T. Prognostic significance of interactions between ER alpha and ER beta and lymph node status in breast cancer cases. Asian Pac J Cancer Prev. 2013;14:6081\u20134.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Ervik M. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:359\u201386.","journal-title":"Int J Cancer."},{"key":"140_CR14","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.7314\/APJCP.2014.15.14.5633","volume":"15","author":"M Agnieszka","year":"2014","unstructured":"Agnieszka M, Magdalena K, Grazyna J, Iwanowicz P. Assessment of midwifery student preparation for erforming the role of breast cancer educator. Asian Pac J Cancer Prev. 2014;15:5633\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR15","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.7314\/APJCP.2012.13.11.5525","volume":"13","author":"S Haghighat","year":"2012","unstructured":"Haghighat S, Akbari M, Ghaffari S, Yavari P. Standardized breast cancer mortality rate compared to the general female population of Iran. Asian Pac J Cancer Prev. 2012;13:5525\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR16","first-page":"77","volume":"5","author":"Y Bhurgri","year":"2004","unstructured":"Bhurgri Y. Karachi cancer registry data implications for the national cancer control program of Pakistan. Asian Pac J Cancer Prev. 2004;5:77\u201382.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR17","first-page":"227","volume":"10","author":"M Hanif","year":"2009","unstructured":"Hanif M, Zaidi P, Kamal S, Hameed A. Institution-based cancer incidence in a local population in Pakistan: 9\u00a0year data analysis. Asian Pac J Cancer Prev. 2009;10:227\u201330.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7314\/APJCP.2012.13.2.693","volume":"13","author":"S Khoker","year":"2012","unstructured":"Khoker S, Muhammad U, Masooma R, Naseem A, Afaf S. Clinico-pathologic profile of breast cancer patients in Pakistan: 10\u00a0years data of a local cancer hospital. Asian Pac J Cancer Prev. 2012;13:693\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR19","first-page":"827","volume":"12","author":"F Badar","year":"2011","unstructured":"Badar F, Faruqui Z, Uddin N. Management of breast lesions by breast physicians in a heavily populated south Asian developing country. Asian Pac J Cancer Prev. 2011;12:827\u201332.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR20","first-page":"49","volume":"10","author":"M Moore","year":"2009","unstructured":"Moore M, Ariyaratne Y, Badar F. Cancer epidemiology in South Asia past, present and future. Asian Pac J Cancer Prev. 2009;10:49\u201367.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR21","first-page":"119","volume":"7","author":"S Jamal","year":"2006","unstructured":"Jamal S, Mamoon N, Mushtaq S, Luqman M. Carcinoma of the male breast: a study of 141 cases from Northern Pakistan. Asian Pac J Cancer Prev. 2006;7:119\u201321.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1158\/1055-9965.EPI-04-0680","volume":"14","author":"L Yang","year":"2005","unstructured":"Yang L, Parkin D, Ferlay J. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev. 2005;14:243\u201350.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"140_CR23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3322\/caac.21335","volume":"66","author":"LA Torre","year":"2016","unstructured":"Torre LA, Sauer AM, Chen MS, Kagawa-Singer M, Jemal A, Siegel RL. Cancer statistics for Asian Americans, native hawaiians, and pacific islanders, 2016: converging incidence in males and females. Cancer J Clin. 2016;66:182\u2013202.","journal-title":"Cancer J Clin."},{"key":"140_CR24","first-page":"55","volume":"9","author":"K Aronson","year":"2000","unstructured":"Aronson K, Miller A, Woolcott C, Sterns E, McCready D, Lickley L, et al. Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Prev Biomarkers. 2000;9:55\u201363.","journal-title":"Cancer Epidemiol Prev Biomarkers"},{"key":"140_CR25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF01570694","volume":"16","author":"G Stark","year":"1992","unstructured":"Stark G, Grandel S, Spilker G. Tissue suction of the male and female breast. Aesth Plast Surg. 1992;16:317\u201324.","journal-title":"Aesth Plast Surg."},{"key":"140_CR26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1072-7515(00)00776-6","volume":"192","author":"P Tanis","year":"2001","unstructured":"Tanis P, Nieweg O, Olmos R, Kroon B. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy1. J Amer Coll Surg. 2001;192:399\u2013409.","journal-title":"J Amer Coll Surg."},{"issue":"1","key":"140_CR27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.1998.tb08197.x","volume":"838","author":"S Thomsen","year":"1998","unstructured":"Thomsen S, Tatman D. Physiological and pathological factors of human breast disease that can influence optical diagnosis. Ann N Y Acad Sci. 1998;838(1):171\u201393.","journal-title":"Ann N Y Acad Sci"},{"key":"140_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/metabo7020025","volume":"7","author":"N Jagannathan","year":"2017","unstructured":"Jagannathan N, Sharma U. Breast tissue metabolism by magnetic resonance spectroscopy. Metabolites. 2017;7:25\u201330.","journal-title":"Metabolites"},{"key":"140_CR29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.reprotox.2017.02.002","volume":"69","author":"L Brayboy","year":"2017","unstructured":"Brayboy L, Oulhen N, Long S, Voigt N, Raker C, Wessel G. Multidrug resistance transporter-1 and breast cancer resistance protein protect against ovarian toxicity, and are essential in ovarian physiology. Rep Toxicol. 2017;69:121\u201331.","journal-title":"Rep Toxicol"},{"key":"140_CR30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ca.22165","volume":"26","author":"F Hassiotou","year":"2013","unstructured":"Hassiotou F, Geddes D. Anatomy of the human mammary gland: current status of knowledge. Clin Anat. 2013;26:29\u201348.","journal-title":"Clin Anat"},{"key":"140_CR31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1075-122X.2004.21375.x","volume":"10","author":"RR Love","year":"2004","unstructured":"Love RR, Love SM, Laudico AV. Breast cancer from a public health perspective. Breast J. 2004;10:136\u201340.","journal-title":"Breast J."},{"key":"140_CR32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bpj.2016.11.687","volume":"112","author":"A West","year":"2017","unstructured":"West A, Wullkopf L, Christensen A, Leijnse N, Tarp JM, Mathiesen J, et al. Division induced dynamics in non-Invasive and invasive breast cancer. Biophys J. 2017;112:123\u20135.","journal-title":"Biophys J"},{"issue":"3","key":"140_CR33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF01974998","volume":"21","author":"MC Posner","year":"1992","unstructured":"Posner MC, Wolmark N. Non-invasive breast carcinoma. Breast Cancer Res Treat. 1992;21(3):155\u201364.","journal-title":"Breast Cancer Res Treat"},{"key":"140_CR34","first-page":"15","volume":"9","author":"J Hang","year":"2017","unstructured":"Hang J, Sim L, Zakaria Z. Non-invasive breast cancer assessment using magnetic induction spectroscopy technique. Int J Integr Eng. 2017;9:15\u201320.","journal-title":"Int J Integr Eng"},{"key":"140_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4048\/jbc.2017.20.1.1","volume":"20","author":"M Inoue","year":"2017","unstructured":"Inoue M, Nakagomi H, Nakada H, Furuya K, Ikegame K, Watanabe H. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer. Breast Cancer. 2017;20:1\u20136.","journal-title":"Breast Cancer"},{"key":"140_CR36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1586\/14737140.2016.1143362","volume":"16","author":"P Clauser","year":"2016","unstructured":"Clauser P, Marino MA, Baltzer PA, Bazzocchi M, Zuiani C. Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ. Exp Rev Anticancer ther. 2016;16:335\u20136.","journal-title":"Exp Rev Anticancer ther."},{"key":"140_CR37","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1200\/JCO.2005.04.038","volume":"23","author":"P Chuba","year":"2005","unstructured":"Chuba P, Hamre M, Yap J, Severson R, Lucas D, Shamsa F. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol. 2005;23:5534\u201341.","journal-title":"J Clin Oncol"},{"key":"140_CR38","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0039-6109(03)00072-0","volume":"83","author":"F Nakhlis","year":"2003","unstructured":"Nakhlis F, Morrow M. Ductal carcinoma in situ. Surg Clin. 2003;83:821\u201339.","journal-title":"Surg Clin"},{"key":"140_CR39","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1200\/JCO.2015.65.2289","volume":"34","author":"LN Harris","year":"2016","unstructured":"Harris LN, Ismaila N, McShane LM, Andre F, Collyar DE, Gonzalez-Angulo AM, et al. Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer. J Clin Oncol. 2016;34:1134\u201350.","journal-title":"J Clin Oncol"},{"key":"140_CR40","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bpj.2015.11.3333","volume":"110","author":"MJ Ziperstein","year":"2016","unstructured":"Ziperstein MJ, Guzman A, Kaufman LJ. Evaluating breast cancer cell morphology as a predictor of invasive capacity. Biophys J. 2016;110:621\u20135.","journal-title":"Biophys J"},{"key":"140_CR41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13058-017-0864-z","volume":"19","author":"S Prabhakaran","year":"2017","unstructured":"Prabhakaran S, Rizk V, Ma Z, Cheng C, Berglund A, Coppola D, et al. Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes. Breast Cancer Res. 2017;19:71\u20134.","journal-title":"Breast Cancer Res"},{"key":"140_CR42","first-page":"309","volume":"35","author":"A Stevanovic","year":"2006","unstructured":"Stevanovic A, Lee P, Wilcken N. Metastatic breast cancer. Aust Fam Phys. 2006;35:309\u201311.","journal-title":"Aust Fam Phys"},{"key":"140_CR43","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1373\/clinchem.2016.261834","volume":"63","author":"K Page","year":"2017","unstructured":"Page K, Guttery D, Fernandez-Garcia D, Hills A, Hastings R, Luo J, et al. Next generation sequencing of circulating cell-free DNA for evaluating mutations and gene amplification in metastatic breast cancer. Clin Chem. 2017;63:532\u201341.","journal-title":"Clin Chem"},{"key":"140_CR44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/bcr767","volume":"6","author":"G Arpino","year":"2004","unstructured":"Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004;6:149\u201352.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"140_CR45","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/pmic.200300560","volume":"3","author":"R Somiari","year":"2003","unstructured":"Somiari R, Sullivan A, Russell S, Somiari S, Hu H, Jordan R, George A, Katenhusen R, Buchowiecka A, Arciero C, Brzeski H. High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics. 2003;3(10):1863\u201373.","journal-title":"Proteomics"},{"key":"140_CR46","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1245\/s10434-016-5649-6","volume":"24","author":"A Mateo","year":"2017","unstructured":"Mateo A, Pezzi T, Sundermeyer M, Kelley C, Klimberg V, Pezzi C. Chemotherapy significantly improves survival for patients with T1c-T2N0M0 medullary Breast cancer. Ann Surg Oncol. 2017;24:1050\u20136.","journal-title":"Ann Surg Oncol."},{"key":"140_CR47","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.5455\/2320-6012.ijrms201411102","volume":"2","author":"D Anuradha","year":"2017","unstructured":"Anuradha D, Lakshmi A. Mucinous carcinoma of breast with neuroendocrine differentiation: a rare case report with review of literature. Int J Res Med Sci. 2017;2:1751\u20134.","journal-title":"Int J Res Med Sci."},{"key":"140_CR48","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.18203\/2320-6012.ijrms20172496","volume":"5","author":"V Priya","year":"2017","unstructured":"Priya V, Prasaad P. Tubulo-lobular carcinoma: a rare mixed invasive carcinoma of breast. Int J Res Med Sci. 2017;5:2818\u201320.","journal-title":"Int J Res Med Sci."},{"key":"140_CR49","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neo.2017.03.002","volume":"19","author":"M Joglekar-Javadekar","year":"2017","unstructured":"Joglekar-Javadekar M, Van Laere S, Bourne M, Moalwi M, Finetti P, Vermeulen PB, et al. Characterization and targeting of platelet-derived growth factor receptor alpha (PDGFRA) in inflammatory breast cancer (IBC). Neoplasia. 2017;19:564\u201373.","journal-title":"Neoplasia"},{"key":"140_CR50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.suronc.2005.07.004","volume":"14","author":"M Cariati","year":"2005","unstructured":"Cariati M, Bennett-Britton TM, Pinder SE, Purushotham AD. Inflammatory breast cancer. Surg Oncol. 2005;14:133\u201343.","journal-title":"Surg Oncol"},{"key":"140_CR51","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5021\/ad.2017.29.3.365","volume":"29","author":"E Errichetti","year":"2017","unstructured":"Errichetti E, Avellini C, Pegolo E, De Francesco V. Dermoscopy as a supportive instrument in the early recognition of erosive adenomatosis of the nipple and mammary paget\u2019s disease. Ann Dermatol. 2017;29:365\u20137.","journal-title":"Ann Dermatol"},{"key":"140_CR52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/000313481708300312","volume":"83","author":"A Merrill","year":"2017","unstructured":"Merrill A, White A, Howard-McNatt M. Paget\u2019s disease of the breast: an institutional review and surgical management. Am Surg. 2017;83:96\u20138.","journal-title":"Am Surg."},{"key":"140_CR53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.breast.2017.03.001","volume":"33","author":"M Strode","year":"2017","unstructured":"Strode M, Khoury T, Mangieri C, Takabe K. Update on the diagnosis and management of malignant phyllodes tumors of the breast. J Breast. 2017;33:91\u20136.","journal-title":"J Breast"},{"key":"140_CR54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13104-017-2375-5","volume":"10","author":"T Sera","year":"2017","unstructured":"Sera T, Kashiwagi S, Takashima T, Asano Y, Goto W, Iimori N, et al. Multiple metastatic malignant phyllodes tumor of the breast with tonsillar metastasis: a case report. BMC Res Notes. 2017;10:55\u201360.","journal-title":"BMC Res Notes"},{"key":"140_CR55","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10549-017-4156-1","volume":"162","author":"S Nozad","year":"2017","unstructured":"Nozad S, Sheehan C, Gay L, Elvin J, Vergilio J, Suh J, et al. Comprehensive genomic profiling of malignant phyllodes tumors of the breast. Breast Cancer Res Treat. 2017;162:597\u2013602.","journal-title":"Breast Cancer Res Treat"},{"key":"140_CR56","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","volume":"26","author":"C Liedtke","year":"2008","unstructured":"Liedtke C, Mazouni C, Hess KR, Andr\u00e9 F, Tordai A, Mejia JA, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008;26:1275\u201381.","journal-title":"J Clin Oncol"},{"key":"140_CR57","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"W Foulkes","year":"2010","unstructured":"Foulkes W, Smith I, Reis-Filho J. Triple-negative breast cancer. New Engl J Med. 2010;363:1938\u201348.","journal-title":"New Engl J Med"},{"key":"140_CR58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10911-005-2540-7","volume":"10","author":"J Stingl","year":"2005","unstructured":"Stingl J, Raouf A, Emerman JT, Eaves CJ. Epithelial progenitors in the normal human mammary gland. J Mammary Gland Biol Neoplasia. 2005;10:49\u201359.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"1","key":"140_CR59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1083\/jcb.200611114","volume":"177","author":"R Villadsen","year":"2007","unstructured":"Villadsen R, Fridriksdottir AJ, R\u00f8nnov-Jessen L, et al. Evidence for a stem cell hierarchy in the adult human breast. J Cell Biol. 2007;177(1):87\u2013101.","journal-title":"J Cell Biol"},{"key":"140_CR60","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.4161\/cc.5.14.2983","volume":"5","author":"J Stingl","year":"2006","unstructured":"Stingl J, Raouf A, Eirew P, Eaves CJ. Deciphering the mammary epithelial cell hierarchy. Cell Cycle. 2006;5:1519\u201322.","journal-title":"Cell Cycle"},{"key":"140_CR61","first-page":"4763","volume":"42","author":"B Gusterson","year":"1982","unstructured":"Gusterson B, Warburton MJ, Mitchell D, Ellison M, Neville AM, Rudland PS. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res. 1982;42:4763\u201370.","journal-title":"Cancer Res"},{"key":"140_CR62","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"G Evan","year":"2001","unstructured":"Evan G, Vousden K. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342\u20138.","journal-title":"Nature"},{"key":"140_CR63","first-page":"211","volume":"11","author":"X Grana","year":"1995","unstructured":"Grana X, Reddy E. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene. 1995;11:211\u201320.","journal-title":"Oncogene"},{"key":"140_CR64","first-page":"1821","volume":"266","author":"L Hartwell","year":"1994","unstructured":"Hartwell L, Kastan M. Cell cycle control and cancer. Sci. 1994;266:1821\u20133.","journal-title":"Cell cycle control and cancer. Sci."},{"key":"140_CR65","first-page":"575","volume":"20","author":"J Leighton","year":"1960","unstructured":"Leighton J, Kalla R, Turner J, Fennell R. Pathogenesis of tumor invasion. Cancer Res. 1960;20:575\u201386.","journal-title":"Cancer Res"},{"key":"140_CR66","first-page":"63","volume":"1766","author":"E Cavalieri","year":"2006","unstructured":"Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, et al. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta. 2006;1766:63\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"140_CR67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejca.2010.09.005","volume":"47","author":"T Jarde","year":"2011","unstructured":"Jarde T, Perrier S, Vasson M, Caldefie-Chezet F. Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer. 2011;47:33\u201343.","journal-title":"Eur J Cancer"},{"key":"140_CR68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg R. The hallmarks of cancer. Cell. 2000;100:57\u201370.","journal-title":"Cell"},{"key":"140_CR69","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"R Jain","year":"2005","unstructured":"Jain R. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307:58\u201362.","journal-title":"Science"},{"key":"140_CR70","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"G Gupta","year":"2006","unstructured":"Gupta G, Massagu\u00e9 J. Cancer metastasis: building a framework. Cell. 2006;127:679\u201395.","journal-title":"Cell"},{"key":"140_CR71","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7314\/APJCP.2013.14.1.183","volume":"14","author":"U Shamsi","year":"2013","unstructured":"Shamsi U, Khan S, Usman S, Soomro S, Azam I. A multicenter matched case control study of breast cancer risk factors among women in Karachi, Pakistan. Asian Pac J Cancer Prev. 2013;14:183\u20138.","journal-title":"Asian Pac J Cancer Prev."},{"issue":"8","key":"140_CR72","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.7314\/APJCP.2013.14.8.4519","volume":"14","author":"T Donnelly","year":"2013","unstructured":"Donnelly T, Khater A, Al-Bader S. Arab women\u2019s breast cancer screening practices: a literature review. Asian Pac J Cancer Prev. 2013;14(8):4519\u201328.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR73","first-page":"24","volume":"5","author":"I Harirchi","year":"2004","unstructured":"Harirchi I, Karbakhsh M, Kashefi A, Momtahen A. Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev. 2004;5:24\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR74","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.7314\/APJCP.2012.13.5.1881","volume":"13","author":"M Kadivar","year":"2012","unstructured":"Kadivar M, Mafi N, Joulaee A. Breast cancer molecular subtypes and associations with clinicopathological characteristics in Iranian women, 2002\u20132011. Asian Pac J Cancer Prev. 2012;13:1881\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR75","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.7314\/APJCP.2013.14.4.2207","volume":"14","author":"M Alegre","year":"2013","unstructured":"Alegre M, Knowles M, Robison R, O\u2019Neill K. Mechanics behind breast cancer prevention-focus on obesity, exercise and dietary fat. Asian Pac J Cancer Prev. 2013;14:2207\u201312.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR76","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.7314\/APJCP.2013.14.4.2649","volume":"14","author":"N Zainal","year":"2013","unstructured":"Zainal N, Nik-Jaafar N, Baharudin A, Sabki Z, Ng C. Prevalence of depression in breast cancer survivors: a systematic review of observational studies. Asian Pac J Cancer Prev. 2013;14:2649\u201356.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR77","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.7314\/APJCP.2014.15.5.2267","volume":"15","author":"I Andsoy","year":"2014","unstructured":"Andsoy I, Gul A. Breast, cervix and colorectal cancer knowledge among nurses in turkey. Asian Pac J Cancer Prev. 2014;15:2267\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR78","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.7314\/APJCP.2012.13.11.5327","volume":"13","author":"A Franca","year":"2012","unstructured":"Franca A, Ferreira M, Franca J, Franca E, Honorio-Franca A. Breastfeeding and its relationship with reduction of breast cancer: a review. Asian Pac J Cancer Prev. 2012;13:5327\u201332.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR79","first-page":"513","volume":"8","author":"J Kruk","year":"2007","unstructured":"Kruk J. Association of lifestyle and other risk factors with breast cancer according to menopausal status: a case-control study in the region of Western Pomerania (Poland). Asian Pac J Cancer Prev. 2007;8:513\u20134.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR80","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJM199902113400604","volume":"340","author":"T Jacobs","year":"1999","unstructured":"Jacobs T, Byrne C, Colditz G, Connolly J, Schnitt S. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. New Engl J Med. 1999;340:430\u20136.","journal-title":"New Engl J Med"},{"key":"140_CR81","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.7314\/APJCP.2014.15.3.1357","volume":"15","author":"G Alco","year":"2014","unstructured":"Alco G, Igdem S, Dincer M. Vitamin D levels in patients with breast cancer: importance of dressing style. Asian Pac J Cancer Prev. 2014;15:1357\u201362.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR82","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/pon.1678","volume":"19","author":"I Hasson-Ohayon","year":"2010","unstructured":"Hasson-Ohayon I, Goldzweig G, Braun M, Galinsky D. Women with advanced breast cancer and their spouses: diversity of support and psychological distress. PsychoOncology. 2010;19:1195\u2013204.","journal-title":"PsychoOncology"},{"key":"140_CR83","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bmj.321.7261.624","volume":"321","author":"K McPherson","year":"2000","unstructured":"McPherson K, Steel C, Dixon J. Breast cancer-epidemiology, risk factors, and genetics. Brit Med J. 2000;321:624\u20138.","journal-title":"Brit Med J."},{"key":"140_CR84","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.pu.17.050196.000403","volume":"17","author":"J Kelsey","year":"1996","unstructured":"Kelsey J, Bernstein L. Epidemiology and prevention of breast cancer. Ann Rev Public Health. 1996;17:47\u201367.","journal-title":"Ann Rev Public Health."},{"key":"140_CR85","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa044383","volume":"353","author":"L Hartmann","year":"2005","unstructured":"Hartmann L, Sellers T, Frost M, Lingle W, Degnim A, Suman V. Benign breast disease and the risk of breast cancer. New Engl J Med. 2005;353:229\u201337.","journal-title":"New Engl J Med."},{"key":"140_CR86","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3122\/jabfm.18.3.211","volume":"18","author":"M Eberl","year":"2005","unstructured":"Eberl M, Sunga A, Farrell C, Mahoney M. Patients with a family history of cancer: identification and management. JABFM. 2005;18:211\u20137.","journal-title":"JABFM"},{"key":"140_CR87","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1470-2045(00)00254-0","volume":"2","author":"T Key","year":"2001","unstructured":"Key T, Verkasalo P, Banks E. Epidemiology of breast cancer. The lancet Oncol. 2001;2:133\u201340.","journal-title":"The lancet Oncol."},{"key":"140_CR88","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/oxfordjournals.epirev.a036108","volume":"15","author":"DB Thomas","year":"1993","unstructured":"Thomas DB. Breast cancer in men. Epidemiol Rev. 1993;15:220\u201331.","journal-title":"Epidemiol Rev"},{"key":"140_CR89","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.drup.2005.06.002","volume":"8","author":"O Weinberg","year":"2005","unstructured":"Weinberg O, Marquez-Garban D, Pietras R. New approaches to reverse resistance to hormonal therapy in human breast cancer. Drug Resist Updat. 2005;8:219\u201333.","journal-title":"Drug Resist Updat."},{"key":"140_CR90","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/jcb.20566","volume":"96","author":"R Singh","year":"2005","unstructured":"Singh R, Kumar R. Steroid hormone receptor signalling in tumorigenesis. J Cell Biochem. 2005;96:490\u2013505.","journal-title":"J Cell Biochem"},{"key":"140_CR91","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00280-005-0102-8","volume":"56","author":"S Kato","year":"2005","unstructured":"Kato S, Sato T, Watanabe T, Takemasa S, Masuhiro Y, Ohtake F. Function of nuclear sex hormone receptors in gene regulation. Cancer Chemother Pharmacol. 2005;56:4\u20139.","journal-title":"Cancer Chemother Pharmacol"},{"key":"140_CR92","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.breast.2004.12.008","volume":"15","author":"N Malara","year":"2006","unstructured":"Malara N, Leotta A, Sidoti A, Lio S, D\u2019Angelo R, Caparello B, et al. Ageing, hormonal behaviour and cyclin D1 in ductal breast carcinomas. Breast. 2006;15:81\u20139.","journal-title":"Breast"},{"issue":"337","key":"140_CR93","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0140-6736(91)92867-2","volume":"8","author":"H Lee","year":"1991","unstructured":"Lee H, Lee J, Gourley L, Duffy S, Day N, Est\u00e8ve J. Dietary effects on breast-cancer risk in Singapore. Lancet. 1991;8(337):1197\u2013200.","journal-title":"Lancet"},{"key":"140_CR94","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(95)92713-1","volume":"346","author":"B Hulka","year":"1995","unstructured":"Hulka B, Stark T. Breast cancer: cause and prevention. Lancet. 1995;346:883\u20137.","journal-title":"Lancet"},{"key":"140_CR95","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/mc.22538","volume":"56","author":"M Zhao","year":"2017","unstructured":"Zhao M, Howard E, Parris A, Guo Z, Zhao Q, Yang X. Alcohol promotes migration and invasion of triple-negative breast cancer cells through activation of p38 MAPK and JNK. Mol Carcinogen. 2017;56:849\u201362.","journal-title":"Mol Carcinogen."},{"key":"140_CR96","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah P, Narod S. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72:1117\u201330.","journal-title":"Am J Hum Genet"},{"key":"140_CR97","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00439-003-0908-6","volume":"112","author":"C Scott","year":"2003","unstructured":"Scott C, Jenkins M, Southey M. Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics. Hum Genet. 2003;112:542\u201351.","journal-title":"Hum Genet"},{"key":"140_CR98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2003.10.005","volume":"205","author":"A Nkondjock","year":"2004","unstructured":"Nkondjock A, Ghadirian P. Epidemiology of breast cancer among BRCA mutation carriers: an overview. Cancer Lett. 2004;205:1\u20138.","journal-title":"Cancer Lett"},{"key":"140_CR99","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.7314\/APJCP.2013.14.10.5625","volume":"14","author":"U Shaukat","year":"2013","unstructured":"Shaukat U, Ismail M, Mehmood N. Epidemiology, major risk factors and genetic predisposition for breast cancer in the Pakistani population. Asian Pac J Cancer Prev. 2013;14:5625\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR100","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00006842-199707000-00011","volume":"59","author":"E Heim","year":"1997","unstructured":"Heim E, Valach L, Schaffner L. Coping and psychosocial adaptation: longitudinal effects over time and stages in breast cancer. Psychosom Med. 1997;59:408\u201318.","journal-title":"Psychosom Med"},{"issue":"1","key":"140_CR101","first-page":"11","volume":"3","author":"A Bednarek","year":"1997","unstructured":"Bednarek A, Sahin A, Brenner A, Johnston D, Aldaz C. Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage. Clin Cancer Res. 1997;3(1):11\u20136.","journal-title":"Clin Cancer Res"},{"key":"140_CR102","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2001.19.3.657","volume":"19","author":"R Segal","year":"2001","unstructured":"Segal R, Evans W, Johnson D, Smith J, Colletta S, Gayton J. Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol. 2001;19:657\u201365.","journal-title":"J Clin Oncol"},{"key":"140_CR103","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijrobp.2013.11.012","volume":"88","author":"M Moran","year":"2014","unstructured":"Moran M, Schnitt S, Giuliano A, Harris J, Khan S, Horton J. Society of surgical oncology\u2013American society for radiation oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Rad Oncol Biol Phys. 2014;88:553\u201364.","journal-title":"Int J Rad Oncol Biol Phys."},{"key":"140_CR104","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/1097-0142(19900701)66:1<119::AID-CNCR2820660122>3.0.CO;2-3","volume":"66","author":"C Jacquillat","year":"1990","unstructured":"Jacquillat C, Weil M, Baillet F, Borel C, Auclerc G, Maublanc M. Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer. 1990;66:119\u201329.","journal-title":"Cancer"},{"key":"140_CR105","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/cncr.24873","volume":"116","author":"H Neuman","year":"2015","unstructured":"Neuman H, Morrogh M, Gonen M. Stage IV breast cancer in the Era of targeted therapy, Does surgery of the primary tumor matter. Cancer. 2015;116:1226\u201333.","journal-title":"Cancer"},{"issue":"20","key":"140_CR106","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1001\/jama.1993.03510200050031","volume":"270","author":"K Kerlikowske","year":"1993","unstructured":"Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V. Positive predictive value of screening mammography by age and family history of breast cancer. JAMA. 1993;270(20):2444\u201350.","journal-title":"JAMA"},{"key":"140_CR107","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5306\/wjco.v5.i3.283","volume":"5","author":"R Shah","year":"2014","unstructured":"Shah R, Rosso K, Nathanson SD. Pathogenesis, prevention, diagnosis and treatment of breast cancer. World J Clin Oncol. 2014;5:283\u20138.","journal-title":"World J Clin Oncol."},{"key":"140_CR108","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1148\/radiol.2251011667","volume":"225","author":"T Kolb","year":"2002","unstructured":"Kolb T, Lichy J, Newhouse J. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002;225:165\u201375.","journal-title":"Radiology"},{"key":"140_CR109","first-page":"3373","volume":"2","author":"J Kosters","year":"2003","unstructured":"Kosters J, G\u00f8tzsche P. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev. 2003;2:3373\u20135.","journal-title":"Cochrane Database Syst Rev"},{"key":"140_CR110","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2702.2004.01108.x","volume":"14","author":"T McCready","year":"2005","unstructured":"McCready T, Littlewood D, Jenkinson J. Breast self-examination and breast awareness: a literature review. J Clin Nurs. 2005;14:570\u20138.","journal-title":"J Clin Nurs"},{"key":"140_CR111","first-page":"765","volume":"10","author":"A Gursoy","year":"2009","unstructured":"Gursoy A, Hindistan S, Nurall N. A comparison of three educational interventions on breast self examination knowledge and health belief. Asian Pac J Cancer Prev. 2009;10:765\u201372.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR112","first-page":"1173","volume":"12","author":"A Redhwan","year":"2011","unstructured":"Redhwan A, Al-Naggar D, Bobryshev Y, Chen R, Assabri A. Practice and barriers toward breast self-examination among young Malaysian women. Asian Pac J Cancer Prev. 2011;12:1173\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR113","first-page":"1167","volume":"11","author":"H Taha","year":"2010","unstructured":"Taha H, Halabi Y, Berggren V. Educational intervention to improve breast health knowledge among women in Jordan. Asian Pac J Cancer Prev. 2010;11:1167\u201373.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR114","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.7314\/APJCP.2012.13.9.4593","volume":"13","author":"S Alipour","year":"2012","unstructured":"Alipour S, Moini A, Jafari-Adli S, Gharaie N, Mansouri K. Comparison of teaching about breast cancer via mobile or traditional learning methods in gynecology residents. Asian Pac J Cancer Prev. 2012;13:4593\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR115","first-page":"651","volume":"11","author":"J Sreedharan","year":"2010","unstructured":"Sreedharan J, Muttappallymyalil J, Venkatramana M, Thomas M. Breast self-examination and practice among nurses in United Arab Emirates. Asian Pac J Cancer Prev. 2010;11:651\u20134.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR116","first-page":"1569","volume":"11","author":"A Ozkan","year":"2010","unstructured":"Ozkan A, Malak A, G\u00fcrkan A, Turgay A. Do Turkish nursing and midwifery students teach breast self examination to their relatives. Asian Pac J Cancer Prev. 2010;11:1569\u201373.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR117","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.7314\/APJCP.2013.14.10.5877","volume":"14","author":"E Ceber","year":"2013","unstructured":"Ceber E, Mermer G, Okcin F. Breast cancer risk and early diagnosis applications in Turkish women aged 50 and over. Asian Pac J Cancer Prev. 2013;14:5877\u201382.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR118","first-page":"1761","volume":"11","author":"K Beydag","year":"2010","unstructured":"Beydag K, Karao\u011flan P. The effect of breast self examination (Bse) education given to midwifery students on their knowledge and attitudes. Asian Pac J Cancer Prev. 2010;11:1761\u20134.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR119","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1001\/jama.299.18.2151","volume":"299","author":"W Berg","year":"2008","unstructured":"Berg W, Blume J, Cormack J, Mendelson E, Lehrer D, Bohm-Velez M, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299:2151\u201363.","journal-title":"JAMA"},{"key":"140_CR120","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/PAP.0b013e31821698cc","volume":"18","author":"S Masood","year":"2011","unstructured":"Masood S, Rosa M. Borderline breast lesions: diagnostic challenges and clinical implications. Adv Anat Pathol. 2011;18:190\u20138.","journal-title":"Adv Anat Pathol"},{"key":"140_CR121","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s00330-009-1588-y","volume":"20","author":"K Kelly","year":"2010","unstructured":"Kelly K, Dean J, Comulada W, Lee S. Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. Eur Radiol. 2010;20:734\u201342.","journal-title":"Eur Radiol"},{"key":"140_CR122","first-page":"101","volume":"11","author":"B Ahmed","year":"2010","unstructured":"Ahmed B. Awareness and practice of breast cancer and breast self examination among university students in Yemen. Asian Pac J Cancer Prev. 2010;11:101\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR123","first-page":"49","volume":"10","author":"O Cam","year":"2009","unstructured":"Cam O, Gvmvs A. Breast cancer screening behavior in Turkish women: relationships with health beliefs and self-esteem, body, perception and hopelessness. Asian Pac J Cancer Prev. 2009;10:49\u201356.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR124","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.semnuclmed.2006.08.001","volume":"37","author":"D Husarik","year":"2007","unstructured":"Husarik D, Steinert H. Single-photon emission computed tomography\/computed tomography for sentinel node mapping in breast cancer. Semin Nuclear Med. 2007;37:29\u201333.","journal-title":"Semin Nuclear Med"},{"key":"140_CR125","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1200\/JCO.2004.08.120","volume":"22","author":"G Antoch","year":"2004","unstructured":"Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T, et al. Accuracy of whole-body dual-modality fluorine-18\u20132-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET\/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol. 2004;22:4357\u201368.","journal-title":"J Clin Oncol"},{"issue":"11","key":"140_CR126","first-page":"157","volume":"2010","author":"M Porika","year":"2010","unstructured":"Porika M, Malotu N, Veldandi U-K. Evaluation of tumor markers in Southern Indian breast cancer patients. Asian Pac J Cancer Prev. 2010;2010(11):157\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR127","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1200\/JCO.2007.14.2364","volume":"25","author":"L Harris","year":"2007","unstructured":"Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25:5287\u2013312.","journal-title":"J Clin Oncol"},{"key":"140_CR128","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/oxfordjournals.annonc.a058385","volume":"4","author":"DF Hayes","year":"1993","unstructured":"Hayes DF. Tumor markers for breast cancer. Ann Oncol. 1993;4:807\u201319.","journal-title":"Ann Oncol"},{"key":"140_CR129","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/107327481502200214","volume":"22","author":"L Khazai","year":"2015","unstructured":"Khazai L, Rosa M. Use of immunohistochemical stains in epithelial lesions of the breast. Cancer Control. 2015;22:220\u20135.","journal-title":"Cancer Control"},{"key":"140_CR130","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(02)08020-0","volume":"359","author":"L Nystrom","year":"2002","unstructured":"Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskj\u00f6ld B, Rutqvist L. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909\u201319.","journal-title":"Lancet"},{"key":"140_CR131","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3747\/co.2007.117","volume":"14","author":"H Richardson","year":"2007","unstructured":"Richardson H, Johnston D, Pater J, Goss P. The national cancer institute of Canada clinical trials group MAP.3 trial: an international breast cancer prevention trial. Curr Oncol. 2007;14:89\u201396.","journal-title":"Curr Oncol."},{"key":"140_CR132","first-page":"282","volume":"27","author":"J Boughey","year":"2016","unstructured":"Boughey J, Nguyen T. Axillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph bodes. Breast Dis YB Quart. 2016;27:282\u20134.","journal-title":"Breast Dis YB Quart"},{"issue":"3","key":"140_CR133","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/bcr433","volume":"4","author":"C Sotiriou","year":"2002","unstructured":"Sotiriou C, Powles TJ, Dowsett M, Jazaeri AA, Feldman AL, Assersohn L, Gadisetti C, Libutti SK, Liu ET. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer. Breast Cancer Res. 2002;4(3):3\u20137.","journal-title":"Breast Cancer Res"},{"key":"140_CR134","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0959-8049(02)00501-4","volume":"39","author":"V Kuenen-Boumeester","year":"2003","unstructured":"Kuenen-Boumeester V, Menke-Pluymers M, Kanter A, Obdeijn I, Urich D, Kwast T. Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients. Eur J Cancer. 2003;39:170\u20134.","journal-title":"Eur J Cancer"},{"issue":"2","key":"140_CR135","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1148\/radiology.188.2.8327696","volume":"188","author":"EL Elvecrog","year":"1993","unstructured":"Elvecrog EL, Lechner MC, Nelson MT. Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results. Radiology. 1993;188(2):453\u20135.","journal-title":"Radiology"},{"issue":"3","key":"140_CR136","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiology.192.3.8058949","volume":"192","author":"L Liberman","year":"1994","unstructured":"Liberman L, Dershaw DD, Rosen PP, Abramson AF, Deutch BM, Hann LE. Stereotaxic 14-gauge breast biopsy: how many core biopsy specimens are needed. Radiology. 1994;192(3):793\u20135.","journal-title":"Radiology"},{"key":"140_CR137","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/sj.bjc.6601290","volume":"89","author":"A Damera","year":"2003","unstructured":"Damera A, Evans A, Cornford E, Wilson A, Burrell H, James J, et al. Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer. Brit J Cancer. 2003;89:1310.","journal-title":"Brit J Cancer"},{"key":"140_CR138","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1148\/radiology.204.2.9240540","volume":"204","author":"R Jackman","year":"1997","unstructured":"Jackman R, Burbank F, Parker S, Evans P, Lechner C, Richardson T, et al. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology. 1997;204:485\u20138.","journal-title":"Radiology"},{"key":"140_CR139","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/archsurg.135.6.700","volume":"135","author":"W Burak","year":"2000","unstructured":"Burak W, Owens K, Tighe M, Kemp L, Dinges S, Olsen J. Vacuum-assisted stereotactic breast biopsy: histologic underestimation of malignant lesions. Arch Surg. 2000;135:700\u20133.","journal-title":"Arch Surg"},{"key":"140_CR140","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0960-7404(93)90064-6","volume":"2","author":"D Krag","year":"1993","unstructured":"Krag D, Weaver D, Alex J, Fairbank J. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335\u201340.","journal-title":"Surg Oncol"},{"key":"140_CR141","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","volume":"32","author":"G Lyman","year":"2014","unstructured":"Lyman G, Temin S, Edge S, Newman L, Turner R, Weaver D, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32:1365\u201383.","journal-title":"J Clin Oncol"},{"key":"140_CR142","first-page":"569","volume":"2","author":"S Abdulkareem","year":"2014","unstructured":"Abdulkareem S. Breast magnetic resonance imaging indications in current practice. Asian Pac J Cancer Prev. 2014;2:569\u201375.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR143","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7314\/APJCP.2012.13.3.969","volume":"13","author":"M Ahmadian","year":"2012","unstructured":"Ahmadian M, Samah A, Redzuan M, Emby Z. Predictors of mammography screening among Iranian women attending outpatient clinics in Tehran, Iran. Asian Pac J Cancer Prev. 2012;13:969\u201374.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR144","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.7314\/APJCP.2013.14.4.2277","volume":"4","author":"F Wang","year":"2013","unstructured":"Wang F, Chen F, Yin H. Effects of age, breast density and volume on breast cancer diagnosis: a retrospective comparison of sensitivity of mammography and ultrasonography in China\u2019s rural areas. Asian Pac J Cancer Prev. 2013;4:2277\u201382.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR145","first-page":"1965","volume":"12","author":"K Kanaga","year":"2011","unstructured":"Kanaga K, Nithiya J, Shatirah M. Awareness of breast cancer and screening procedures among Malaysian women. Asian Pac J Cancer Prev. 2011;12:1965\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR146","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2214\/ajr.183.4.1831149","volume":"183","author":"F Sardanelli","year":"2004","unstructured":"Sardanelli F, Giuseppetti G, Panizza P, Bazzocchi M, Fausto A, Simonetti G, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. Am J Roentgenol. 2004;183:1149\u201357.","journal-title":"Am J Roentgenol."},{"key":"140_CR147","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1075-122X.2006.00200.x","volume":"12","author":"R Smith","year":"2006","unstructured":"Smith R, Caleffi M, Albert S, Tony H, Stephen W, Franceschi D. Breast cancer in limited resource countries: early detection and access to care. Breast J. 2006;12:16\u201326.","journal-title":"Breast J."},{"issue":"4","key":"140_CR148","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1075-122X.2006.00269.x","volume":"12","author":"W Berg","year":"2006","unstructured":"Berg W, Weinberg I, Narayanan D, Lobrano M, Ross E, Levine E. High-resolution fluorodeoxyglucose positron emission tomography with compression (\u201cpositron emission mammography\u201d) is highly accurate in depicting primary breast cancer. Breast J. 2006;12(4):309\u201323.","journal-title":"Breast J"},{"key":"140_CR149","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00259-010-1588-9","volume":"38","author":"K Schilling","year":"2011","unstructured":"Schilling K, Narayanan D, Judith E, Velasquez M, Kahn S, Saady M. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging. Eur J Nucl Med Mol Imaging. 2011;38:23\u201336.","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"119","key":"140_CR150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.steroids.2017.01.002","volume":"31","author":"X Meng","year":"2017","unstructured":"Meng X, Sun H, Yang L, Yin R, Qi L. A hydroxylated flavonol, fisetin inhibits the formation of a carcinogenic estrogen metabolite. Steroids. 2017;31(119):53\u20136.","journal-title":"Steroids"},{"key":"140_CR151","first-page":"2255","volume":"12","author":"S Oshima","year":"2011","unstructured":"Oshima S, Kisa K, Terashita T. A qualitative study of Japanese patients\u2019 perspectives on post-treatment care for gynecological cancer. Asian Pac J Cancer Prev. 2011;12:2255\u201361.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR152","doi-asserted-by":"crossref","first-page":"695","DOI":"10.7314\/APJCP.2014.15.2.695","volume":"15","author":"E Sharifa","year":"2014","unstructured":"Sharifa E, Fuad I, Hayati Y. Observational Study on patient\u2019s satisfactions and quality of life (QoL) among cancer patients receiving treatment with palliative care intent in a tertiary hospital in Malaysia. Asian Pac J Cancer Prev. 2014;15:695\u2013701.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR153","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.7314\/APJCP.2012.13.8.3747","volume":"13","author":"F Shen","year":"2012","unstructured":"Shen F, Liu M, Zhang X. Health-related quality of life among breast cancer patients and its influencing factor in a Chinese population. Asian Pac J Cancer Prev. 2012;13:3747\u201350.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR154","first-page":"2111","volume":"12","author":"R Lodha","year":"2011","unstructured":"Lodha R, Nandeshwar S, Pal D. Risk factors for breast cancer among women in Bhopal urban agglomerate: a case-control study. Asian Pac J Cancer Prev. 2011;12:2111\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"140_CR155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/138920106775789638","volume":"7","author":"M Debnath","year":"2006","unstructured":"Debnath M, Malik C, Bisen P. Micropropagation: a tool for the production of high quality plant-based medicines. Curr Pharm Biotechnol. 2006;7(1):33\u20139.","journal-title":"Curr Pharm Biotechnol"},{"key":"140_CR156","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s11095-010-0085-y","volume":"27","author":"R Mehta","year":"2010","unstructured":"Mehta R, Murillo G, Naithani R, Peng X. Cancer chemoprevention by natural products: how far have we come. Pharm Res. 2010;27:950\u201361.","journal-title":"Pharm Res"},{"key":"140_CR157","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7314\/APJCP.2013.14.1.413","volume":"14","author":"Q Deng","year":"2013","unstructured":"Deng Q, Huang X, Ye L. Phase II trial of Loubo\u00ae (Lobaplatin) and Pemetrexed for patients with metastatic breast cancer not responding to anthracycline or taxanes. Asian Pac J Cancer Prev. 2013;14:413\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR158","first-page":"1034","volume":"9","author":"S Huang","year":"2010","unstructured":"Huang S, Cao K. Anti-invasive and anti-metastasis effect of norcantharidin on high-metastatic human breast cancer cell lines. J Trop Med. 2010;9:1034\u201345.","journal-title":"J Trop Med"},{"key":"140_CR159","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1200\/JCO.2005.09.548","volume":"23","author":"J Savard","year":"2005","unstructured":"Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects. J Clin Oncol. 2005;23:6083\u201396.","journal-title":"J Clin Oncol"},{"key":"140_CR160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/1467-8721.00180","volume":"11","author":"BE Compas","year":"2002","unstructured":"Compas BE, Luecken L. Psychological adjustment to breast cancer. Curr Direct Psychol Sci. 2002;11:111\u20134.","journal-title":"Curr Direct Psychol Sci"},{"key":"140_CR161","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1200\/JCO.2016.69.4406","volume":"35","author":"M Ellis","year":"2017","unstructured":"Ellis M, Suman V, Hoog J, Goncalves R, Sanati S, Creighton CJ, et al. Ki67 proliferation index as a tool for chemotherapy decisions during and after neoadjuvant aromatase inhibitor treatment of breast cancer: results from the American college of surgeons oncology group Z1031 trial (Alliance). J Clin Oncol. 2017;35:1061\u20139.","journal-title":"J Clin Oncol"},{"key":"140_CR162","first-page":"1","volume":"6","author":"N Houssami","year":"2017","unstructured":"Houssami N, Turner R, Morrow M. Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer. Breast Cancer Res Treat. 2017;6:1\u201311.","journal-title":"Breast Cancer Res Treat"},{"key":"140_CR163","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejso.2017.01.039","volume":"43","author":"R Pearson","year":"2017","unstructured":"Pearson R, Milligan R, Cain H. Radioactive iodine-125 seed localisation of breast carcinoma in advance of the day of surgery reduces pre-operative anxiety levels. Europ J Surg Oncol. 2017;43:7\u201310.","journal-title":"Europ J Surg Oncol."},{"issue":"3","key":"140_CR164","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10549-016-3707-1","volume":"155","author":"I Vaz-Luis","year":"2016","unstructured":"Vaz-Luis I, Hughes ME, Cronin A, Rugo HS, Edge SB, Moy B, Theriault RL, Hassett MJ, Winer EP, Lin NU. Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers. Breast Cancer Res Treat. 2016;155(3):569\u201378.","journal-title":"Breast Cancer Res Treat"},{"key":"140_CR165","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199511303332203","volume":"333","author":"B Fisher","year":"1995","unstructured":"Fisher B, Anderson S, Redmond C, Cronin W. Reanalysis and results after 12\u00a0years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. New Engl J Med. 1995;333:1456\u201361.","journal-title":"New Engl J Med"},{"key":"140_CR166","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2130::AID-CNCR11>3.0.CO;2-8","volume":"83","author":"M Dorval","year":"1998","unstructured":"Dorval M, Maunsell E, Desch\u00eanes L, Brisson J. Type of mastectomy and quality of life for long term breast carcinoma survivors. Cancer. 1998;83:2130\u20138.","journal-title":"Cancer"},{"key":"140_CR167","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","volume":"75","author":"J Yarnold","year":"2005","unstructured":"Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol. 2005;75:9\u201317.","journal-title":"Radiother Oncol"},{"key":"140_CR168","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1200\/JCO.2001.19.6.1688","volume":"19","author":"A Voogd","year":"2001","unstructured":"Voogd A, Nielsen M, Peterse JL, Blichert-Toft M, Bartelink H, Overgaard M, et al. Danish breast cancer cooperative group and the breast cancer cooperative group of the European organization for research and treatment of cancer. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol. 2001;19:1688\u201397.","journal-title":"J Clin Oncol"},{"key":"140_CR169","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"T Rebbeck","year":"2004","unstructured":"Rebbeck T, Friebel T, Lynch H, Neuhausen S, Veer L, Garber J, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol. 2004;22:1055\u201362.","journal-title":"J Clin Oncol"},{"key":"140_CR170","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1200\/JCO.2007.12.3141","volume":"25","author":"T Tuttle","year":"2007","unstructured":"Tuttle T, Habermann E, Grund E, Morris T, Virnig B. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25:5203\u20139.","journal-title":"J Clin Oncol"},{"key":"140_CR171","first-page":"425","volume":"12","author":"G Keskin","year":"2011","unstructured":"Keskin G, Gumus A. Turkish hysterectomy and mastectomy patients-depression, body image, sexual problems and spouse relationships. Asian Pac J Cancer Prev. 2011;12:425\u201332.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR172","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/jnci\/92.17.1422","volume":"92","author":"JH Rowland","year":"2000","unstructured":"Rowland JH, Desmond KA, Meyerowitz BE, Belin TR, Wyatt GE. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Nat Cancer Instit. 2000;92:1422\u20139.","journal-title":"J Nat Cancer Instit."},{"key":"140_CR173","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1245\/s10434-007-9413-9","volume":"14","author":"P Parker","year":"2007","unstructured":"Parker P, Youssef A, Walker S. Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancer. Ann Surg Oncol. 2007;14:3078\u201389.","journal-title":"Ann Surg Oncol"},{"key":"140_CR174","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.breast.2004.10.008","volume":"14","author":"EE Elder","year":"2005","unstructured":"Elder EE, Brandberg Y, Bj\u00f6rklund T. Quality of life and patient satisfaction in breast cancer patients after immediate breast reconstruction: a prospective study. Breast. 2005;14:201\u20138.","journal-title":"Breast"},{"key":"140_CR175","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1054\/brst.2002.0451","volume":"11","author":"C Thomson","year":"2002","unstructured":"Thomson C, Twelves C, Mallon E, Leake R, Group S. Scottish cancer therapy network. adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status. Breast. 2002;11:419\u201329.","journal-title":"Breast"},{"key":"140_CR176","first-page":"67","volume":"30","author":"N Davidson","year":"2001","unstructured":"Davidson N. Ovarian ablation as adjuvant therapy for breast cancer. Semin Oncol. 2001;30:67\u201371.","journal-title":"Semin Oncol."},{"key":"140_CR177","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5858\/134.7.e48","volume":"134","author":"M Hammond","year":"2010","unstructured":"Hammond M, Hayes D, Dowsett M, Allred D, Hagerty K, Badve S, et al. American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med. 2010;134:48\u201372.","journal-title":"Arch Pathol Lab Med"},{"key":"140_CR178","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U","volume":"46","author":"C Osborne","year":"1980","unstructured":"Osborne C, Yochmowitz M, Knight W, McGuire W. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer. 1980;46:2884\u20138.","journal-title":"Cancer"},{"key":"140_CR179","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1038\/sj.onc.1206937","volume":"22","author":"R Clarke","year":"2003","unstructured":"Clarke R, Liu M, Bouker K, Gu Z, Lee R, Zhu Y. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene. 2003;22:7316\u201339.","journal-title":"Oncogene"},{"key":"140_CR180","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000068332","volume":"77","author":"S Mehta","year":"2003","unstructured":"Mehta S, Dhandapani K, De Sevilla L, Webb R, Mahesh V. Tamoxifen, a selective estrogen receptor modulator, reduces ischemic damage caused by middle cerebral artery occlusion in the ovariectomized female rat. Neuroendocrinology. 2003;77:44\u201350.","journal-title":"Neuroendocrinology"},{"key":"140_CR181","first-page":"2731","volume":"62","author":"S Man","year":"2002","unstructured":"Man S, Bocci G, Francia G, Green S, Jothy S, Hanahan D. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. Cancer Res. 2002;62:2731\u20135.","journal-title":"Cancer Res"},{"key":"140_CR182","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2008.20.5179","volume":"27","author":"K Visvanathan","year":"2009","unstructured":"Visvanathan K, Chlebowski R, Hurley P, Col F, Ropka M, Collyar D. American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol. 2009;27:3235\u201358.","journal-title":"J Clin Oncol"},{"key":"140_CR183","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1517\/14740338.7.3.241","volume":"7","author":"F Journe","year":"2008","unstructured":"Journe F, Body J, Leclercq G, Laurent G. Hormone therapy for breast cancer, with an emphasis on the pure antiestrogen fulvestrant: mode of action, antitumor efficacy and effects on bone health. Exp Opin Drug Safe. 2008;7:241\u201358.","journal-title":"Exp Opin Drug Safe"},{"key":"140_CR184","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJMra022219","volume":"348","author":"B Riggs","year":"2003","unstructured":"Riggs B, Hartmann L. Selective estrogen-receptor modulators\u2014mechanisms of action and application to clinical practice. New Engl J Med. 2003;348:618\u201329.","journal-title":"New Engl J Med"},{"key":"140_CR185","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/jnci\/83.20.1450","volume":"83","author":"S Nayfield","year":"1991","unstructured":"Nayfield S, Karp J, Ford L, Dorr F, Kramer B. Potential role of tamoxifen in prevention of breast cancer. J Nat Cancer Inst. 1991;83:1450\u20139.","journal-title":"J Nat Cancer Inst"},{"key":"140_CR186","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.steroids.2007.07.009","volume":"72","author":"V Jordan","year":"2007","unstructured":"Jordan V. New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer. Steroids. 2007;72:829\u201342.","journal-title":"Steroids"},{"key":"140_CR187","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino J, Wickerham D, Redmond C, Kavanah M, Cronin W, et al. Tamoxifen for prevention of breast cancer: report of the national surgical adjuvant breast and bowel project P-1 Study. J Nat Cancer Inst. 1998;90:1371\u201388.","journal-title":"J Nat Cancer Inst"},{"key":"140_CR188","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino J, Wickerham D. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371\u201388.","journal-title":"J Natl Cancer Inst"},{"key":"140_CR189","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","volume":"295","author":"V Vogel","year":"2006","unstructured":"Vogel V, Costantino J, Wickerham D. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP study of tamoxifen and raloxifene (STAR) P-2 trial. JAMA. 2006;295:2727\u201341.","journal-title":"JAMA"},{"key":"140_CR190","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(03)12342-2","volume":"361","author":"J Cuzick","year":"2003","unstructured":"Cuzick J, Powles T, Veronesi U. Overview of the main outcomes in breast-cancer prevention trials. Lancet. 2003;361:296\u2013300.","journal-title":"Lancet"},{"key":"140_CR191","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/jnci\/djk049","volume":"99","author":"J Cuzick","year":"2007","unstructured":"Cuzick J, Forbes J, Sestak I. Long-term results of tamoxifen prophylaxis for breast cancer\u201496-month follow-up of the randomized IBIS-I trial. J Natl Cancer Inst. 2007;99:272\u201382.","journal-title":"J Natl Cancer Inst"},{"key":"140_CR192","first-page":"652","volume":"17","author":"J Mortimer","year":"2003","unstructured":"Mortimer J, Urban J. Long-term toxicities of selective estrogen-receptor modulators and antiaromatase agents. J Oncol. 2003;17:652\u20139.","journal-title":"J Oncol."},{"key":"140_CR193","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11864-007-0019-z","volume":"8","author":"V Vogel","year":"2007","unstructured":"Vogel V. Chemoprevention strategies 2006. Curr Treat Options Oncol. 2007;8:74\u201388.","journal-title":"Curr Treat Options Oncol"},{"key":"140_CR194","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1001\/jama.295.23.joc60075","volume":"295","author":"S Land","year":"2006","unstructured":"Land S, Wickerham D, Costantino J. Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006;295:2742\u201351.","journal-title":"JAMA"},{"key":"140_CR195","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1200\/JCO.2001.19.3.881","volume":"19","author":"P Goss","year":"2001","unstructured":"Goss P, Strasser K. Aromatase inhibitors in the treatment and prevention of breast cancer. J Clin Oncol. 2001;19:881\u201394.","journal-title":"J Clin Oncol"},{"key":"140_CR196","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.2005.09.121","volume":"23","author":"E Winer","year":"2005","unstructured":"Winer E, Hudis C, Burstein H, Wolff A, Pritchard K, Ingle J, et al. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor\u2013positive breast cancer: status report 2004. J Clin Oncol. 2005;23:619\u201329.","journal-title":"J Clin Oncol"},{"key":"140_CR197","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1259\/bjr\/01948454","volume":"81","author":"E Hall","year":"2008","unstructured":"Hall E, Brenner D. Cancer risks from diagnostic radiology. Br J Radiol. 2008;81:362\u201378.","journal-title":"Br J Radiol"},{"key":"140_CR198","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.7314\/APJCP.2014.15.6.2505","volume":"15","author":"M Nandi","year":"2014","unstructured":"Nandi M, Mahata A, Mallick I. Hypofractionated radiotherapy for breast cancers\u2013preliminary results from a tertiary care center in eastern India. Asian Pac J Cancer Prev. 2014;15:2505\u201310.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR199","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.7314\/APJCP.2012.13.4.1131","volume":"13","author":"S Zhou","year":"2012","unstructured":"Zhou S, Shi W, Meng D. Interoperative radiotherapy of seventy-two cases of early breast cancer patients during breast-conserving surgery. Asian Pac J Cancer Prev. 2012;13:1131\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0360-3016(02)04277-3","volume":"55","author":"M Keisch","year":"2003","unstructured":"Keisch M, Vicini F, Kuske R, Hebert M, White J, Quiet C, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55:289\u201393.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"140_CR201","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9610(00)00454-2","volume":"180","author":"A King","year":"2000","unstructured":"King A, Bolton J, Kuske R, Fuhrman G, Scroggins T, Jiang X. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T is, 1, 2 breast cancer. Am J Surg. 2000;180:299\u2013304.","journal-title":"Am J Surg"},{"key":"140_CR202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","volume":"108","author":"R Johnstone","year":"2002","unstructured":"Johnstone R, Ruefli A, Lowe S. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 2002;108:153\u201364.","journal-title":"Cell"},{"key":"140_CR203","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/1745505716677139","volume":"12","author":"S Masood","year":"2016","unstructured":"Masood S. Neoadjuvant chemotherapy in breast cancers. Womens Health (Lond). 2016;12:480\u201391.","journal-title":"Womens Health (Lond)"},{"issue":"16","key":"140_CR204","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1200\/JCO.2004.05.063","volume":"22","author":"I Benson","year":"2004","unstructured":"Benson I, Schrag D, Somerfield M, Cohen A, Figueredo A, Flynn P. American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22(16):3408\u201319.","journal-title":"J Clin Oncol"},{"key":"140_CR205","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1056\/NEJM200106283442607","volume":"344","author":"C Shapiro","year":"2001","unstructured":"Shapiro C, Recht A. Side effects of adjuvant treatment of breast cancer. New Engl J Med. 2001;344:1997\u20132008.","journal-title":"New Engl J Med."},{"key":"140_CR206","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A Muller","year":"2001","unstructured":"Muller A, Homey B, Soto H, Ge N. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50\u20135.","journal-title":"Nature"},{"key":"140_CR207","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1056\/NEJMoa072113","volume":"357","author":"K Miller","year":"2007","unstructured":"Miller K, Wang M, Gralow J, Dickler M, Cobleigh M, Perez E. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. New Engl J Med. 2007;357:2666\u201376.","journal-title":"New Engl J Med"},{"key":"140_CR208","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jnci\/83.4.288","volume":"83","author":"I Ringel","year":"1991","unstructured":"Ringel I, Horwitz S. Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Nat Cancer Inst. 1991;83:288\u201391.","journal-title":"J Nat Cancer Inst"},{"key":"140_CR209","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/02841860310017748","volume":"43","author":"E Wist","year":"2004","unstructured":"Wist E, Sommer H, Ostenstad B, Risberg T, Fjaestad K. Weekly 1-hour paclitaxel as first-line chemotherapy for metastatic breast cancer. Acta Oncol. 2004;43:11\u20134.","journal-title":"Acta Oncol"},{"key":"140_CR210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10549-007-9756-8","volume":"111","author":"D Tan","year":"2008","unstructured":"Tan D, Marchi\u00f3 C, Jones R, Savage K, Smith I, Dowsett M, et al. Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Treat. 2008;111:27\u201344.","journal-title":"Breast Cancer Res Treat"},{"key":"140_CR211","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1200\/JCO.2002.09.002","volume":"20","author":"J Oshaughnessy","year":"2002","unstructured":"Oshaughnessy J, Miles D, Vukelja S, Moiseyenko V, Ayoub JP, Cervantes G, et al. Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol. 2002;20:2812\u201323.","journal-title":"J Clin Oncol"},{"key":"140_CR212","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/annonc\/mdi088","volume":"16","author":"E Grevelman","year":"2005","unstructured":"Grevelman E, Breed W. Prevention of chemotherapy-induced hair loss by scalp cooling. Ann Oncol. 2005;16:352\u20138.","journal-title":"Ann Oncol"},{"key":"140_CR213","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijcard.2010.03.003","volume":"144","author":"J Monsuez","year":"2010","unstructured":"Monsuez J, Charniot JC, Vignat N, Artigou JY. Cardiac side-effects of cancer chemotherapy. Int J Cardiol. 2010;144:3\u201315.","journal-title":"Int J Cardiol."},{"issue":"20","key":"140_CR214","first-page":"34","volume":"2002","author":"L Digianni","year":"2002","unstructured":"Digianni L, Garber J, Winer E. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol. 2002;2002(20):34\u20138.","journal-title":"J Clin Oncol"},{"key":"140_CR215","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s00520-004-0770-7","volume":"13","author":"J Yates","year":"2005","unstructured":"Yates J, Mustian K, Morrow G, Gillies L, Padmanaban D, Atkins J. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer. 2005;13:806\u201311.","journal-title":"Support Care Cancer"},{"key":"140_CR216","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/ije\/30.3.526","volume":"30","author":"K Linde","year":"2001","unstructured":"Linde K, Jonas W, Melchart D, Willich S. The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol. 2001;30:526\u201331.","journal-title":"Int J Epidemiol"},{"key":"140_CR217","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0020-7489(02)00005-6","volume":"39","author":"S Thorne","year":"2002","unstructured":"Thorne S, Paterson B, Russell C, Schultz A. Complementary\/alternative medicine in chronic illness as informed self-care decision making. Int J Nurs Stud. 2002;39:671\u201383.","journal-title":"Int J Nurs Stud."},{"key":"140_CR218","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/(SICI)1097-0215(19970317)70:6<699::AID-IJC12>3.0.CO;2-5","volume":"70","author":"S Wang","year":"1997","unstructured":"Wang S, Hsu L, Hsu H, Lee S, Shiao M, Ho C. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer. 1997;70:699\u2013705.","journal-title":"Int J Cancer."},{"key":"140_CR219","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1207\/s15327914nc4902_13","volume":"49","author":"J Jiang","year":"2004","unstructured":"Jiang J, Slivova V, Harvey K. Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt\/NF-kappaB signaling. Nutr Cancer. 2004;49:209\u201316.","journal-title":"Nutr Cancer"},{"key":"140_CR220","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1248\/cpb.54.1017","volume":"54","author":"L Harinantenaina","year":"2006","unstructured":"Harinantenaina L, Tanaka M, Takaoka S, Oda M, Mogami O, Uchida M. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem Pharm Bull. 2006;54:1017\u201321.","journal-title":"Chem Pharm Bull"},{"key":"140_CR221","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ajhp\/60.4.356","volume":"60","author":"E Basch","year":"2003","unstructured":"Basch E, Gabardi S, Ulbricht C. Bitter melon (Momordica charantia): a review of efficacy and safety. Amer J HealthSyst Pharm. 2003;60:356\u20139.","journal-title":"Amer J HealthSyst Pharm"},{"key":"140_CR222","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1158\/0008-5472.CAN-09-3438","volume":"70","author":"B Ray","year":"2010","unstructured":"Ray B, Raychoudhuri A, Steele R. Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Res. 2010;70:1925\u201331.","journal-title":"Cancer Res"},{"key":"140_CR223","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1248\/bpb.27.1976","volume":"27","author":"J Roh","year":"2004","unstructured":"Roh J, Han J, Kim J, Hwang J. Inhibitory effects of active compounds isolated from safflower (Carthamus tinctorius L.) seeds for melanogenesis. Biol Pharm Bull. 2004;27:1976\u20138.","journal-title":"Biol Pharm Bull"},{"key":"140_CR224","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1248\/cpb.45.1910","volume":"45","author":"H Zhang","year":"1997","unstructured":"Zhang H, Nagatsu A, Watanabe T. Antioxidative compounds isolated from safflower (Carthamus tinctorius L.) oil cake. Chem Pharm Bull. 1997;45:1910\u20134.","journal-title":"Chem Pharm Bull"},{"key":"140_CR225","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ptr.3622","volume":"26","author":"T Takahashi","year":"2012","unstructured":"Takahashi T, Miyazawa M. Potent \u03b1-glucosidase inhibitors from safflower (Carthamus tinctorius L.) seed. Phytother Res. 2012;26:722\u20136.","journal-title":"Phytother Res."},{"key":"140_CR226","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.lfs.2004.06.021","volume":"76","author":"T Loo","year":"2004","unstructured":"Loo T, Cheung N, Chow W. The inhibitory effect of herbal formula comprising ginseng and Carthamus tinctorius on breast cancer. Life Sci. 2004;76:191\u2013200.","journal-title":"Life Sci"},{"key":"140_CR227","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1211\/0022357055083","volume":"57","author":"K Urech","year":"2005","unstructured":"Urech K, Scher J, Hostanska K, Becker H. Apoptosis inducing activity of viscin, a lipophilic extract from Viscum album L. J Pharm Pharmacol. 2005;57:101\u20139.","journal-title":"J Pharm Pharmacol"},{"key":"140_CR228","first-page":"57","volume":"7","author":"R Grossarth-Maticek","year":"2001","unstructured":"Grossarth-Maticek R, Kiene H, Baumgartner S, Ziegler R. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern Ther Health Med. 2001;7:57.","journal-title":"Altern Ther Health Med"},{"key":"140_CR229","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1756-9966-28-79","volume":"28","author":"S Gunver","year":"2009","unstructured":"Gunver S, Anja G, Michael S. Viscom album extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research. J Exp Clin Cancer Res. 2009;28:79.","journal-title":"J Exp Clin Cancer Res"},{"key":"140_CR230","first-page":"37","volume":"47","author":"A Pintea","year":"2003","unstructured":"Pintea A, Bele C, Andrei S, Socaciu C. HPLC analysis of carotenoids in four varieties of Calendula officinalis L. flowers. Acta Biol. 2003;47:37\u201340.","journal-title":"Acta Biol"},{"key":"140_CR231","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1021\/np068016b","volume":"69","author":"M Ukiya","year":"2006","unstructured":"Ukiya M, Akihisa T, Yasukawa K, Tokuda H, Suzuki T. Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers. J Nat Products. 2006;69:1692\u20136.","journal-title":"J Nat Products."},{"key":"140_CR232","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1200\/JCO.2004.07.063","volume":"22","author":"P Pommier","year":"2004","unstructured":"Pommier P, Gomez F, Sunyach P. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol. 2004;22:1447\u201353.","journal-title":"J Clin Oncol"},{"key":"140_CR233","first-page":"109","volume":"14","author":"A Delazar","year":"2006","unstructured":"Delazar A, Gibbons S, Kosari A, Nazemiyeh H, Modarresi M, Nahar L. Flavone C-glycosides and cucurbitacin glycosides from Citrullus colocynthis. DARU J Pharm Sci. 2006;14:109\u201314.","journal-title":"DARU J Pharm Sci"},{"key":"140_CR234","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcp.2006.09.012","volume":"73","author":"T Tannin-Spitz","year":"2007","unstructured":"Tannin-Spitz T, Grossman S, Dovrat S, Gottlieb H, Bergman M. Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells. Biochem Pharmacol. 2007;73:56\u201367.","journal-title":"Biochem Pharmacol"},{"key":"140_CR235","first-page":"215","volume":"58","author":"S Kumar","year":"2008","unstructured":"Kumar S, Kumar D, Jusha M, Saroha K, Singh N, Vashishta B. Antioxidant and free radical scavenging potential of Citrullus colocynthis (L.) Schrad. methanolic fruit extract. Acta Pharm. 2008;58:215\u201320.","journal-title":"Acta Pharm"},{"key":"140_CR236","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2008.01.033","volume":"262","author":"J Weng","year":"2008","unstructured":"Weng J, Tsai C, Kulp S, Chen C. Indole-3-carbinol as a chemopreventive and anti-cancer agent. Cancer Lett. 2008;262:153\u201363.","journal-title":"Cancer Lett"},{"key":"140_CR237","first-page":"1283","volume":"18","author":"Z Maasomi","year":"2017","unstructured":"Maasomi Z, Soltanahmadi Y, Dadashpour M, Alipour S, Abolhasani S, Zarghami N. Synergistic anticancer effects of silibinin and chrysin in T47D breast cancer cells. Asian Pac J Cancer Prev. 2017;18:1283\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"key":"140_CR238","first-page":"1","volume":"1","author":"H Maroof","year":"2012","unstructured":"Maroof H, Hassan Z, Mobarez A, Mohamadabadi M. Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J Clin Immunol. 2012;1:1\u20137.","journal-title":"J Clin Immunol"},{"key":"140_CR239","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jso.2930150111","volume":"15","author":"K McConnell","year":"1980","unstructured":"McConnell K, Jager R, Bland K, Blotcky A. The relationship of dietary selenium and breast cancer. J Surg Oncol. 1980;15:67\u201370.","journal-title":"J Surg Oncol"},{"key":"140_CR240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(07)60028-2","volume":"369","author":"I Smith","year":"2007","unstructured":"Smith I, Procter M, Gelber RD, Guillaume S, Feyereislova A, Dowsett M, et al. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet. 2007;369:29\u201336.","journal-title":"Lancet"},{"key":"140_CR241","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1200\/JCO.2002.20.3.719","volume":"20","author":"C Vogel","year":"2002","unstructured":"Vogel C, Cobleigh M, Tripathy D, Gutheil J, Harris L, Fehrenbacher L, et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol. 2002;20:719\u201326.","journal-title":"J Clin Oncol"},{"key":"140_CR242","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1515\/biol-2016-0013","volume":"11","author":"Q Liang","year":"2016","unstructured":"Liang Q, Li W, Zhao Z, Fu Q. Advancement of Wnt signal pathway and the target of breast cancer. Open Life Sci. 2016;11:98\u2013104.","journal-title":"Open Life Sci"},{"issue":"2","key":"140_CR243","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/cncr.29615","volume":"122","author":"JE Churpek","year":"2016","unstructured":"Churpek JE, Marquez R, Neistadt B, Claussen K, Lee MK, Churpek MM, Huo D, Weiner H, Bannerjee M, Godley LA, Le Beau MM. Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia. Cancer. 2016;122(2):304\u201311.","journal-title":"Cancer"},{"key":"140_CR244","first-page":"136","volume":"7","author":"E Bon","year":"2016","unstructured":"Bon E, Driffort V, Gradek F, Martinez-Caceres C, Anchelin M, Pelegrin P, et al. SCN4B acts as a metastasis-suppressor gene preventing hyperactivation of cell migration in breast cancer. Nat Commun. 2016;7:136\u20138.","journal-title":"Nat Commun"},{"key":"140_CR245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2016;534:47\u201354.","journal-title":"Nature"},{"issue":"2","key":"140_CR246","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2217\/fon.15.278","volume":"12","author":"R Manchanda","year":"2016","unstructured":"Manchanda R, Jacobs I. Genetic screening for gynecological cancer: where are we heading? Future Oncol. 2016;12(2):207\u201320.","journal-title":"Future Oncol"},{"key":"140_CR247","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/bcr26","volume":"2","author":"P Obermiller","year":"1999","unstructured":"Obermiller P, Tait D, Holt J. Gene therapy for carcinoma of the breast: therapeutic genetic correction strategies. Breast Cancer Res. 1999;2:28\u201330.","journal-title":"Breast Cancer Res"},{"key":"140_CR248","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin M, Greten FR. NF-[kappa] B: linking inflammation and immunity to cancer development and progression. Nature Rev Immunol. 2005;5:749\u201352.","journal-title":"Nature Rev Immunol."},{"key":"140_CR249","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1634\/theoncologist.9-4-361","volume":"4","author":"C Osborne","year":"2004","unstructured":"Osborne C, Wilson P, Tripathy D. Oncogenes and tumor suppressor genes in breast cancer. Potential diagnostic and therapeutic applications. Oncologist. 2004;4:361\u201377.","journal-title":"Oncologist"},{"key":"140_CR250","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2231-4040.72251","volume":"1","author":"G Sharma","year":"2010","unstructured":"Sharma G, Dave R, Sanadya J, Sharma P, Sharma K. Various types and management of breast cancer: an overview. J Adv Pharm Technol Res. 2010;1:109\u201311.","journal-title":"J Adv Pharm Technol Res."},{"issue":"11","key":"140_CR251","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jcp.2011.090456","volume":"64","author":"S Ricardo","year":"2011","unstructured":"Ricardo S, Vieira AF, Gerhard R, Leit\u00e3o D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J Clin Pathol. 2011;64(11):937\u201346.","journal-title":"J Clin Pathol"},{"key":"140_CR252","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1200\/JCO.2008.16.3931","volume":"26","author":"M Kakarala","year":"2008","unstructured":"Kakarala M, Wicha M. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol. 2008;26:2813\u201320.","journal-title":"J Clin Oncol"},{"key":"140_CR253","first-page":"43","volume":"13","author":"P Noyce","year":"2017","unstructured":"Noyce P. Improving long-term adjuvant anti-oestrogenic therapy for breast cancer. New Commun. 2017;13:43\u20137.","journal-title":"New Commun"},{"key":"140_CR254","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1158\/0008-5472.CAN-16-1593","volume":"77","author":"T Shibata","year":"2017","unstructured":"Shibata T, Watari K, Izumi H, Kawahara A, Hattori S, Fukumitsu C, et al. Breast cancer resistance to antiestrogens is enhanced by increased ER degradation and ERBB2 expression. Cancer Res. 2017;77:545\u201356.","journal-title":"Cancer Res"},{"key":"140_CR255","first-page":"1","volume":"3","author":"T Awolaran","year":"2015","unstructured":"Awolaran T. Cellular mechanisms of estrogen in breast cancer development. J Sci Technol. 2015;3:1\u20137.","journal-title":"J Sci Technol"},{"issue":"11","key":"140_CR256","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"D Slamon","year":"2001","unstructured":"Slamon D, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. New Engl J Med. 2001;344(11):783\u201392.","journal-title":"New Engl J Med."},{"key":"140_CR257","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","volume":"28","author":"A Stopeck","year":"2010","unstructured":"Stopeck A, Lipton A, Body J, Steger G, Tonkin K, De Boer R, et al. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol. 2010;28:5132\u20139.","journal-title":"J Clin Oncol"},{"key":"140_CR258","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0192-0561(98)00077-0","volume":"21","author":"J Hadden","year":"1999","unstructured":"Hadden J. Review Article The immunology and immunotherapy of breast cancer: an update. Int J Immunopharmacol. 1999;21:79\u2013101.","journal-title":"Int J Immunopharmacol"},{"key":"140_CR259","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/14712598.2012.665445","volume":"12","author":"S Wright","year":"2012","unstructured":"Wright S. Immunotherapy of breast cancer. Expert Opin Biol Ther. 2012;12:479\u201390.","journal-title":"Expert Opin Biol Ther."},{"key":"140_CR260","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1349-7006.2008.00853.x","volume":"99","author":"M Ono","year":"2008","unstructured":"Ono M. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci. 2008;99:1501\u20136.","journal-title":"Cancer Sci"},{"key":"140_CR261","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12885-017-3298-1","volume":"17","author":"J Mu","year":"2017","unstructured":"Mu J, Zhu D, Shen Z, Ning S, Liu Y, Chen J. The repressive effect of miR-148a on Wnt\/\u03b2-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells. BMC Cancer. 2017;17:307\u20139.","journal-title":"BMC Cancer."},{"key":"140_CR262","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1200\/JCO.2004.06.080","volume":"22","author":"G Bock de","year":"2004","unstructured":"de Bock G, Bonnema J, van der Hage J, Kievit J, van de Velde C. Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol. 2004;22:4010\u20138.","journal-title":"J Clin Oncol"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-017-0140-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T08:38:31Z","timestamp":1719477511000},"score":1,"resource":{"primary":{"URL":"http:\/\/biolres.biomedcentral.com\/articles\/10.1186\/s40659-017-0140-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,2]]},"references-count":262,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["140"],"URL":"https:\/\/doi.org\/10.1186\/s40659-017-0140-9","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,2]]},"article-number":"33"}}